Our Mission

At Paragonix, our mission is to create a new standard for organ transport that improves patient outcomes worldwide. We strive to protect the ultimate donation with the respect and safety it deserves. A patient’s future is full of uncertainty when they need a transplant, the care of their donor organ shouldn’t be. 

About Paragonix Technologies

Paragonix Technologies markets organ transportation devices that safeguard organs during the journey between donor and recipient patients. Our devices incorporate clinically proven and medically trusted cold preservation techniques in a novel suspension system to provide unprecedented physical and thermal protection. Paragonix SherpaPakTM CTS is the only commercially available FDA cleared and CE marked transport device for heart transportation. Paragonix is also developing transport devices for the lung and kidneys designed to improve donor organ quality and extending donor organ transport time.
SherpaPak canister

Meet The Team

Bill Edelman

Bill Edelman

Executive Chairman & Chief Executive Officer
Lisa Anderson

Lisa Anderson, Ph.D.

Co-Founder, President & Chief Operating Officer
Neal Beswick

Neal Beswick

Chief Commercial Officer
Adam Collette

Adam Collette, Ph.D.

Vice President Commercial Operations
Denise Weber

Denise Weber

Vice President of Operations
Thomas Hartmann

Thomas Hartmann

Vice President Sales EMEA
Cory Reynolds

Cory Reynolds

Midwest Regional Territory Manager
Joe Rago

Joe Rago

Southeast Regional Territory Manager
Meredith Thompson

Meredith Thompson

Mid-Atlantic Regional Territory Manager
Joshua C. Jones, CPTC

Joshua C. Jones, CPTC

United States Clinical Specialist
Antonio Usan Mas

Antonio Usan Mas

Senior Clinical Specialist, Europe
Dan Rabiner

Dan Rabiner

Product Marketing Manager
Julia Hersum

Julia Hersum

GUARDIAN Clinical Coordinator
Melanie Jessel

Melanie Jessel

Senior Product Engineer
Allyson McIntosh

Allyson McIntosh

Product Engineer